WuXi Biologics
WuXi Biologics
WuXi Biologics WuXi AppTec is expected to provide world-class integrated biopharmace
WuXi Biologics is a subsidiary of the WuXi AppTec Group with branches in Wuxi, Shanghai and Suzhou. As a platform for innovative companies to realize their dream of developing new drugs, WuXi AppTec is expected to provide world-class integrated biopharmaceutical R&D and manufacturing services to more innovative biotech companies at home and abroad in the future, accelerating the process of bringing innovative biopharmaceuticals to market in China for the benefit of patients.
- All
- News
- Analysis
- Research
Briefing Nov 20, 2020 08:14 PM
· Healthcare
Pfizer submitted to FDA for authorization of emergency use of new crown vaccine
Briefing Nov 20, 2020 11:57 AM
· Healthcare
The new crown vaccine developed by academician Chen Wei and kangxinuo biology can be stable for a long time from 2 to 8 degrees
In depth
Healthcare
Bid for Molecular Tech in China's Early-Stage Cancer Detection Market
China, with a population of 1.4 billion, has one of the largest gene pools in the world. How does its DNA tech-based cancer detection industry look? Listed on Nasdaq in 2020, Genetron Holdings Limited (Genetron Health) is taking a leading role.
Sep 09, 2020 03:08 PM
Briefing Nov 19, 2020 10:22 AM
· Healthcare
Geli pharmaceutical: asc40 (tvb-2640) China has completed phase II NASH patients
Briefing Nov 19, 2020 09:57 AM
· Healthcare
Heyuan biological has completed a new round of financing of 450 million yuan, and car-t products with independent intellectual property rights have entered clinical phase II
Research
Real Estate, Consumer Discretionary, IndustrialsTech for Global, Globalization Footprints of the Established and the New
May 29, 2020 08:30 PM
Research
Consumer Staples, Industrials, FinancialsLow-Carbon Industry Expansion - Key Studies From Chinese Companies
May 28, 2020 12:40 PM
Apr 26, 2020 03:17 PM
Apr 19, 2020 06:36 PM
Briefing Nov 19, 2020 09:47 AM
· Healthcare
Lukang Pharmaceutical holding subsidiary ambroxol hydrochloride injection obtained drug registration certificate
Briefing Nov 19, 2020 09:33 AM
· Healthcare
Baiji Shenzhou: midterm analysis of the global phase III clinical trial for the treatment of non-small cell lung cancer reached the main end point
Briefing Nov 17, 2020 08:04 PM
· Healthcare
Plan to raise $4 billion! Jingdong health runs IPO
Briefing Nov 11, 2020 10:42 AM
· Healthcare
Drug Innovator Asieris Nabs CNY 700 Million Series D
Healthcare
WIM Presents Next 50 in Global Tech: Healthcare
In 2020, as COVID-19 spread around the world, people began to pay more attention to the healthcare industry. The crisis of the pandemic has led directly to significant changes in the healthcare industry across the globe.
Oct 29, 2020 11:00 AM
Briefing Nov 03, 2020 12:06 PM
· Healthcare
HaoYuan Chemexpress Files for IPO on the Star Market
Briefing Oct 16, 2020 04:24 PM
· Healthcare
Beijing Immunochina Pharmaceutical Closes Series C+ at CNY 100 Mn
Briefing Sep 28, 2020 08:25 PM
· Healthcare
Chinese Biotech Zai Laboratory Lands on HKEX after 3 Years' Listing on Nasdaq
Industrials, Financials, Automotive · Analysis
Black Swans and Breakthroughs: China's Top 50 Innovative Public Firms in 2020
In the times of crisis like COVID-19, even established companies risk falling due to the sudden drop in their income. By contrast, companies that cling to innovation may unlock more value as they fight against the challenges.
Oct 20, 2020 07:40 PM
Briefing Sep 28, 2020 12:12 PM
· Healthcare
AI-Based Drug Research Platform XtalPi Closes Series C at USD 318.8 Mn
Briefing Sep 28, 2020 10:49 AM
· Healthcare
Broncus Biotech Closes Series C of Multi-Tens Millions US Dollars
Briefing Sep 23, 2020 11:37 AM
· Healthcare
Top-Tier CDMO Heyuan China Closes Series C at over CNY 300 Mn
Briefing Sep 23, 2020 11:11 AM
· Healthcare
Tongshu Gene Closes Series B of Multi-Hundreds Millions
See more
Related Companies
EqualOcean Analysis
- China Speed: Two COVID-19 Vaccines Recognized by WHO
- After China's BNR and GTH Hit Nasdaq, Pan-Cancer Detector GRAIL Eyes IPO
- More Room for the Medical Device Market to Grow in China
- Tong Ren Tang: Any Hope for this Purveyor of Centuries-Old Chinese Medicines?
- Modern Chinese Medicine Maker Tasly Pharmaceutical: An Old Stock in a New Package?
EqualOcean is an information service provider and investment research company that aims to become a global platform for industrial innovation. Founded in February 2014 and headquartered in Beijing, with a client network covering over 50 countries, the firm provides comprehensive professional services, including industry research, investment analysis, innovation consulting, data products, corporate branding and international strategy.